|
MAPK1IP1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.0025994458025E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.82249998320816E-09 |
| Normal-vs-Stage2 |
2.96019999623809E-08 |
| Normal-vs-Stage3 |
1.57939999967383E-08 |
| Normal-vs-Stage4 |
3.99080000157426E-08 |
| Stage1-vs-Stage2 |
2.295600E-01 |
| Stage1-vs-Stage3 |
2.167800E-01 |
| Stage1-vs-Stage4 |
1.090190E-02 |
| Stage2-vs-Stage3 |
8.995200E-01 |
| Stage2-vs-Stage4 |
4.851800E-01 |
| Stage3-vs-Stage4 |
3.283200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.80670051036702E-10 |
| Normal-vs-AfricanAmerican |
1.98149999963704E-07 |
| Normal-vs-Asian |
2.577800E-04 |
| Caucasian-vs-AfricanAmerican |
8.082000E-01 |
| Caucasian-vs-Asian |
5.509600E-01 |
| AfricanAmerican-vs-Asian |
4.862600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.85399975558698E-10 |
| Normal-vs-Female |
1.94979998813238E-09 |
| Male-vs-Female |
5.178600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.97210000843995E-09 |
| Normal-vs-Extreme_Weight |
4.51890003194677E-09 |
| Normal-vs-Obese |
2.44320000009068E-07 |
| Normal-vs-Extreme_Obese |
4.35760000000451E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.873400E-01 |
| Normal_Weight-vs-Obese |
2.927000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.976200E-01 |
| Extreme_Weight-vs-Obese |
7.117200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.946600E-01 |
| Obese-vs-Extreme_Obese |
5.235400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.584200E-04 |
| Normal-vs-Age(41-60Yrs) |
6.90750000531537E-08 |
| Normal-vs-Age(61-80Yrs) |
1.03909991722162E-10 |
| Normal-vs-Age(81-100Yrs) |
2.180300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.868800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.387000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.772800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.490280E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.455200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.575400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.95619999777375E-08 |
| Normal-VS-Type2 PRCC |
8.96505092384814E-13 |
| Normal-VS-KIRP CIMP |
5.71750000011306E-07 |
| Normal-VS-Unclassified PRCC |
5.63730000013862E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.241900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.806200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.120220E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.999400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.690400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.806400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.98729921407903E-13 |
| Normal-vs-N1 |
2.52830000047055E-07 |
| Normal-vs-N2 |
6.32679999945651E-07 |
| N0-vs-N1 |
1.105230E-01 |
| N0-vs-N2 |
8.346400E-02 |
| N1-vs-N2 |
2.208300E-02 |
|
|
